default author photo

Amitkumar Mehta

University of Alabama at Birmingham

Birmingham, AL 35294-4460

United States

SCHOLARLY PAPERS

1

DOWNLOADS

81

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Polatuzumab Vedotin in Combination with Immunochemotherapy in Patients with Previously Untreated DLBCL: A Phase 1b/2 Study

Number of pages: 32 Posted: 22 Nov 2018
Herve Tilly, Franck Morschhauser, Nancy L. Bartlett, Amitkumar Mehta, Gilles Salles, Corinne Haioun, Javier Munoz, Andy Chen, Kathryn Kolibaba, Dan Lu, Mark Yan, Elicia Penuel, Jamie Hirata, Calvin Lee and Jeff P. Sharman
University of Rouen - Department of Haematology, University Hospital of Lille, Washington University in St. Louis, University of Alabama at Birmingham, University of Claude Bernard Lyon 1, University Hospital of Henri-Mondor, APHP, University of Texas at Houston - MD Anderson Cancer Center, Oregon Health and Science University, US Oncology Research, Genentech, Inc. - San Francisco, Roche, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and US Oncology Research
Downloads 81 (796,622)

Abstract:

Loading...

B-cell lymphoma, diffuse large B-cell lymphoma, polatuzumab vedotin, antibody drug conjugate, ADC, R-CHOP, CD79b